Consolidated Statements of Equity - USD ($)
$ in Thousands |
Total |
Total Bentley Systems Stockholders' Equity |
Common Stock |
Additional Paid-in Capital |
Accumulated Other Comprehensive Loss |
Accumulated Deficit |
Non-Controlling Interest |
| Beginning balance (in shares) at Dec. 31, 2023 |
|
|
296,265,837
|
|
|
|
|
| Beginning balance at Dec. 31, 2023 |
$ 883,982
|
$ 883,278
|
$ 2,963
|
$ 1,127,234
|
$ (84,987)
|
$ (161,932)
|
$ 704
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Net income (loss) |
142,356
|
142,356
|
|
|
|
142,356
|
|
| Other comprehensive income (loss) |
(8,277)
|
(8,277)
|
|
|
(8,277)
|
|
|
| Dividends declared |
(35,851)
|
(35,851)
|
|
|
|
(35,851)
|
|
| Shares issued in connection with deferred compensation plan, net (in shares) |
|
|
2,474,063
|
|
|
|
|
| Shares issued in connection with deferred compensation plan, net |
0
|
|
$ 24
|
(24)
|
|
|
|
| Deferred compensation plan elective participant deferrals |
101
|
101
|
|
101
|
|
|
|
| Shares issued in connection with executive bonus plan, net (in shares) |
|
|
168,291
|
|
|
|
|
| Shares issued in connection with executive bonus plan, net |
8,916
|
8,916
|
$ 2
|
8,914
|
|
|
|
| Shares issued in connection with employee stock purchase plan, net (in shares) |
|
|
122,020
|
|
|
|
|
| Shares issued in connection with employee stock purchase plan, net |
5,385
|
5,385
|
$ 1
|
5,559
|
|
(175)
|
|
| Stock option exercises, net (in shares) |
|
|
844,283
|
|
|
|
|
| Stock option exercises, net |
1,812
|
1,812
|
$ 8
|
3,999
|
|
(2,195)
|
|
| Shares issued for stock grants, net (in shares) |
|
|
11,391
|
|
|
|
|
| Shares issued for stock grants, net |
600
|
600
|
|
600
|
|
|
|
| Stock-based compensation expense |
30,253
|
30,253
|
|
30,253
|
|
|
|
| Shares related to restricted stock, net (in shares) |
|
|
590,929
|
|
|
|
|
| Shares related to restricted stock, net |
(7,256)
|
(7,256)
|
$ 6
|
(6)
|
|
(7,256)
|
|
| Repurchases of Class B common stock under approved program (in shares) |
|
|
(729,681)
|
|
|
|
|
| Repurchases of Class B common stock under approved program |
(37,515)
|
(37,515)
|
$ (7)
|
|
|
(37,508)
|
|
| Ending balance (in shares) at Jun. 30, 2024 |
|
|
299,747,133
|
|
|
|
|
| Ending balance at Jun. 30, 2024 |
984,506
|
983,802
|
$ 2,997
|
1,176,630
|
(93,264)
|
(102,561)
|
704
|
| Beginning balance (in shares) at Mar. 31, 2024 |
|
|
298,014,682
|
|
|
|
|
| Beginning balance at Mar. 31, 2024 |
932,607
|
931,903
|
$ 2,980
|
1,154,137
|
(92,619)
|
(132,595)
|
704
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Net income (loss) |
72,046
|
72,046
|
|
|
|
72,046
|
|
| Other comprehensive income (loss) |
(645)
|
(645)
|
|
|
(645)
|
|
|
| Dividends declared |
(17,980)
|
(17,980)
|
|
|
|
(17,980)
|
|
| Shares issued in connection with deferred compensation plan, net (in shares) |
|
|
1,936,318
|
|
|
|
|
| Shares issued in connection with deferred compensation plan, net |
0
|
|
$ 19
|
(19)
|
|
0
|
|
| Deferred compensation plan elective participant deferrals |
43
|
43
|
|
43
|
|
|
|
| Shares issued in connection with executive bonus plan, net (in shares) |
|
|
102,352
|
|
|
|
|
| Shares issued in connection with executive bonus plan, net |
5,565
|
5,565
|
$ 1
|
5,564
|
|
0
|
|
| Shares issued for stock grants, net (in shares) |
|
|
11,391
|
|
|
|
|
| Shares issued for stock grants, net |
600
|
600
|
|
600
|
|
|
|
| Stock-based compensation expense |
16,306
|
16,306
|
|
16,306
|
|
|
|
| Shares related to restricted stock, net (in shares) |
|
|
109,473
|
|
|
|
|
| Shares related to restricted stock, net |
(1,527)
|
(1,527)
|
$ 1
|
(1)
|
|
(1,527)
|
|
| Repurchases of Class B common stock under approved program (in shares) |
|
|
(427,083)
|
|
|
|
|
| Repurchases of Class B common stock under approved program |
(22,509)
|
(22,509)
|
$ (4)
|
|
|
(22,505)
|
|
| Ending balance (in shares) at Jun. 30, 2024 |
|
|
299,747,133
|
|
|
|
|
| Ending balance at Jun. 30, 2024 |
984,506
|
983,802
|
$ 2,997
|
1,176,630
|
(93,264)
|
(102,561)
|
704
|
| Beginning balance (in shares) at Dec. 31, 2024 |
|
|
301,977,330
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
1,041,120
|
1,040,987
|
$ 3,020
|
1,217,986
|
(104,078)
|
(75,941)
|
133
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Net income (loss) |
161,838
|
161,850
|
|
|
|
161,850
|
(12)
|
| Other comprehensive income (loss) |
34,991
|
34,983
|
|
|
34,983
|
|
8
|
| Dividends declared |
(42,493)
|
(42,493)
|
|
|
|
(42,493)
|
|
| Shares issued in connection with deferred compensation plan, net (in shares) |
|
|
1,572,829
|
|
|
|
|
| Shares issued in connection with deferred compensation plan, net |
(11,165)
|
(11,165)
|
$ 16
|
(16)
|
|
(11,165)
|
|
| Shares issued in connection with executive bonus plan, net (in shares) |
|
|
49,545
|
|
|
|
|
| Shares issued in connection with executive bonus plan, net |
2,222
|
2,222
|
|
3,124
|
|
(902)
|
|
| Shares issued in connection with employee stock purchase plan, net (in shares) |
|
|
130,212
|
|
|
|
|
| Shares issued in connection with employee stock purchase plan, net |
5,143
|
5,143
|
$ 1
|
5,311
|
|
(169)
|
|
| Shares issued for stock grants, net (in shares) |
|
|
12,591
|
|
|
|
|
| Shares issued for stock grants, net |
600
|
600
|
|
600
|
|
|
|
| Stock-based compensation expense |
32,480
|
32,480
|
|
32,480
|
|
|
|
| Shares related to restricted stock, net (in shares) |
|
|
868,606
|
|
|
|
|
| Shares related to restricted stock, net |
(12,543)
|
(12,543)
|
$ 9
|
(9)
|
|
(12,543)
|
|
| Repurchases of Class B common stock under approved program (in shares) |
|
|
(1,173,041)
|
|
|
|
|
| Repurchases of Class B common stock under approved program |
(50,023)
|
(50,023)
|
$ (12)
|
|
|
(50,011)
|
|
| Ending balance (in shares) at Jun. 30, 2025 |
|
|
303,438,072
|
|
|
|
|
| Ending balance at Jun. 30, 2025 |
1,162,170
|
1,162,041
|
$ 3,034
|
1,259,476
|
(69,095)
|
(31,374)
|
129
|
| Beginning balance (in shares) at Mar. 31, 2025 |
|
|
302,909,806
|
|
|
|
|
| Beginning balance at Mar. 31, 2025 |
1,097,689
|
1,097,582
|
$ 3,029
|
1,239,817
|
(97,583)
|
(47,681)
|
107
|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] |
|
|
|
|
|
|
|
| Net income (loss) |
70,500
|
70,482
|
|
|
|
70,482
|
18
|
| Other comprehensive income (loss) |
28,492
|
28,488
|
|
|
28,488
|
|
4
|
| Dividends declared |
(21,295)
|
(21,295)
|
|
|
|
(21,295)
|
|
| Shares issued in connection with deferred compensation plan, net (in shares) |
|
|
883,626
|
|
|
|
|
| Shares issued in connection with deferred compensation plan, net |
(11,165)
|
(11,165)
|
$ 9
|
(9)
|
|
(11,165)
|
|
| Shares issued in connection with executive bonus plan, net (in shares) |
|
|
26,727
|
|
|
|
|
| Shares issued in connection with executive bonus plan, net |
1,160
|
1,160
|
|
2,062
|
|
(902)
|
|
| Shares issued for stock grants, net (in shares) |
|
|
12,591
|
|
|
|
|
| Shares issued for stock grants, net |
600
|
600
|
|
600
|
|
|
|
| Stock-based compensation expense |
17,007
|
17,007
|
|
17,007
|
|
|
|
| Shares related to restricted stock, net (in shares) |
|
|
104,465
|
|
|
|
|
| Shares related to restricted stock, net |
(809)
|
(809)
|
$ 1
|
(1)
|
|
(809)
|
|
| Repurchases of Class B common stock under approved program (in shares) |
|
|
(499,143)
|
|
|
|
|
| Repurchases of Class B common stock under approved program |
(20,009)
|
(20,009)
|
$ (5)
|
|
|
(20,004)
|
|
| Ending balance (in shares) at Jun. 30, 2025 |
|
|
303,438,072
|
|
|
|
|
| Ending balance at Jun. 30, 2025 |
$ 1,162,170
|
$ 1,162,041
|
$ 3,034
|
$ 1,259,476
|
$ (69,095)
|
$ (31,374)
|
$ 129
|